AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 050 GBX
-0.87%
Updated:
May 6, 2024
AstraZeneca PLC
Operating Expenses
|
AstraZeneca PLC
Operating Expenses Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Operating Expenses
-$28.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-5%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Operating Expenses
-£13.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Operating Expenses
-$67.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Operating Expenses
-$646m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Operating Expenses
-$785m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Operating Expenses
-£404.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-17%
|
See Also
What is AstraZeneca PLC's Operating Expenses?
Operating Expenses
-28.8B
USD
-28.8B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Operating Expenses amounts to -28.8B USD.
What is AstraZeneca PLC's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%
-5%
Over the last year, the Operating Expenses growth was -7%. The average annual Operating Expenses growth rates for AstraZeneca PLC have been -19% over the past three years , -13% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
